Rapid Diagnostic for Human Cytomegalovirus (HCMV) Serological Status
$1,500,000N44FY2019AINIH
Nanocomposix, Inc., San Diego CA
Investigators
Abstract
This proposal aims to develop a point-of-care diagnostic to detect the presence of antibodies against human cytomegalovirus (HCMV).
View original record on NIH RePORTER →